Target Name: OR56A4
NCBI ID: G120793
Review Report on OR56A4 Target / Biomarker Content of Review Report on OR56A4 Target / Biomarker
OR56A4
Other Name(s): olfactory receptor family 56 subfamily A member 4 | O56A4_HUMAN | OR11-49 | olfactory receptor OR11-49 | Olfactory receptor 56A4 | Olfactory receptor OR11-49 | Olfactory receptor, family 56, subfamily A, member 4

OR56A4: A Potential Drug Target and Biomarker

OR56A4 is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. Its primary function is to regulate the levels of insulin in the body. It is a crucial protein that helps keep blood sugar levels under control, and any changes in its expression or function have been linked to various diseases, including diabetes. As a result, OR56A4 has become a focus of interest in the development of new treatments for diabetes and related conditions.

The OR56A4 protein is composed of 56 amino acid residues and has a calculated molecular mass of 74.1 kDa. It is expressed in the brain, pancreas, and gastrointestinal tract, and its levels are regulated by various factors, including blood sugar levels and hormones. OR56A4 has been shown to play a role in the regulation of insulin sensitivity and glucose metabolism.

One of the key functions of OR56A4 is its role in insulin sensitivity. Insulin sensitivity is the ability of tissues to respond to insulin, a hormone that helps regulate blood sugar levels. OR56A4 has been shown to help regulate insulin sensitivity in various tissues, including fat cells and muscle cells. This is important because improved insulin sensitivity is a key factor in the development and progression of type 2 diabetes, a condition in which the body becomes less able to produce or respond to insulin.

Another function of OR56A4 is its role in glucose metabolism. Glucose metabolism is the process by which the body converts food into energy, and OR56A4 is involved in this process by helping to regulate the levels of glucose in the blood. OR56A4 has been shown to play a role in the regulation of glucose uptake and storage in the body's tissues, as well as its release into the bloodstream.

The potential drug target for OR56A4 is related to its role in insulin sensitivity and glucose metabolism. By targeting OR56A4 with drugs, researchers hope to improve insulin sensitivity and reduce the risk of developing type 2 diabetes. This is an important goal because type 2 diabetes is a leading cause of death and disability in the world, and there is a significant need for new treatments that can effectively manage this disease.

In addition to its potential as a drug target, OR56A4 has also been identified as a potential biomarker for the development of type 2 diabetes. The blood levels of OR56A4 have been shown to be reduced in individuals with type 2 diabetes compared to healthy individuals. This suggests that OR56A4 may be a useful biomarker for the diagnosis and monitoring of this disease.

Overall, OR56A4 is a protein that has important functions in the regulation of insulin sensitivity and glucose metabolism. Its potential as a drug target and biomarker make it an attractive target for researchers studying the development and treatment of diabetes and related conditions. Further studies are needed to fully understand the role of OR56A4 in these processes and to develop effective treatments.

Protein Name: Olfactory Receptor Family 56 Subfamily A Member 4

Functions: Odorant receptor

The "OR56A4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR56A4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2 | OR5AK2 | OR5AK4P | OR5AN1 | OR5AP2 | OR5AR1 | OR5AS1 | OR5AU1 | OR5B12 | OR5B17 | OR5B2 | OR5B21 | OR5B3 | OR5BA1P | OR5C1 | OR5D13 | OR5D14 | OR5D16 | OR5D17P | OR5D18 | OR5E1P | OR5F1 | OR5H1 | OR5H14 | OR5H15 | OR5H2 | OR5H4P | OR5H6 | OR5I1 | OR5K1 | OR5K2 | OR5K3 | OR5K4 | OR5L1 | OR5L2 | OR5M1 | OR5M10 | OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P